In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1857 News Items found
Yonina Murciano-Goroff, Jenny Xue, Bob Li, Piro Lito, and Yulei Zhao.
Finding
MSK Researchers Are Learning Why Some Patients Develop Resistance to Targeted Lung Cancer Drug

A paper from MSK researchers reports that resistance to sotorasib, a new targeted drug for lung cancer, can be caused by many different molecular changes.
Paul Marks Prize 2021 winners
Twenty Years Of Honoring A Legacy: Three Investigators Named Winners of Memorial Sloan Kettering Cancer Center’s 2021 Paul Marks Prize for Cancer Research

Memorial Sloan Kettering Cancer Center (MSK) is proud to announce three innovative investigators as the recipients of this year’s Paul Marks Prize for Cancer Research.
Richard J. O'Reilly, MD
A True Giant in Cancer Care: Memorial Sloan Kettering Cancer Center’s Richard J. O’Reilly, MD, Inducted into the 2021 Giants of Cancer Care®

Memorial Sloan Kettering Cancer Center (MSK) is proud to announce that Richard J. O’Reilly, MD, was named to the Ninth Annual Giants of Cancer Care®.
Geneticist Michael Berger
In the Lab
How Do Inherited Gene Mutations Cause Cancer? A New Database Will Help Researchers Find Out

In a new paper, a collaborative team of MSK experts reports how a novel tool will help researchers learn more about the role of inherited hereditary mutations.
Pamela R. Drullinsky
MSK Breast Cancer Expert Shares Tips for Women with Telemundo Audience

MSK’s Pamela Drullinsky, MD, a breast medical oncologist and Regional Care Network Medical Site Director of MSK Nassau, joined one of her patients on a recent segment on Noticiero Telemundo 47 for breast cancer awareness month.
Jianjiong Gao, Hongxin Zhang, Nikolaus Schultz, Debyani Chakravarty, and Sarah Suehnholz stand together on a terrace
Feature
A Milestone for Precision Oncology: FDA Gives Green Light to MSK’s Genetic Database

OncoKB, a database developed and maintained by investigators at MSK, helps match patients with targeted therapies based on the mutations found in their tumors.
Memorial Sloan Kettering researchers Luc Morris and Nils Weinhold
Machine Learning Approach Takes MSK Researchers Beyond Known Method to Predict Immunotherapy Response

Learn about recent research led by MSK physician-scientist Luc Morris, who is trying to better predict who will benefit from immunotherapy.
Man in surgical scrubs looks at reader
True Grit: One Man’s Incredible Journey To Become a Doctor at MSK

Learn how one man's determination to be a doctor took him on an incredible journey from working at a car wash in the Bronx to becoming a physician at Memorial Sloan Kettering Cancer Center, with the help of mentors and a world-class work ethic.
Scientists Learn More about How Lung Cancer Becomes Resistant to Drugs

By switching from one cellular identity to another, lung cancer cells can evade targeted therapies. MSK scientists are trying to stop that from happening.
Memorial Sloan Kettering Cancer Center named to Fast Company's “Brands That Matter” list.
Memorial Sloan Kettering Cancer Center Named in Fast Company’s First Annual List of “Brands That Matter”

Memorial Sloan Kettering Cancer Center (MSK) is proud to announce it has been named to the “Brands that Matter” list by Fast Company.